TMC278

Glaxo J&J Combination May Control HIV With Monthly Injections
Bloomberg
Wed, 07/3/13 - 11:05 am
GSK
JNJ
HIV
GSK744
TMC278
Mylan's Matrix Obtains License for Promising HIV/AIDS Treatment
PR-USA.net
Mon, 01/31/11 - 07:57 am
Mylan
Matrixx
HIV
antiretrovirals
Tibotec
TMC278